These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 18043951

  • 1. Synthesis, in vitro and in vivo characterization of (64)Cu(I) complexes derived from hydrophilic tris(hydroxymethyl)phosphane and 1,3,5-triaza-7-phosphaadamantane ligands.
    Alidori S, Gioia Lobbia G, Papini G, Pellei M, Porchia M, Refosco F, Tisato F, Lewis JS, Santini C.
    J Biol Inorg Chem; 2008 Feb; 13(2):307-15. PubMed ID: 18043951
    [Abstract] [Full Text] [Related]

  • 2. Development of Novel PSMA Ligands for Imaging and Therapy with Copper Isotopes.
    Carlos Dos Santos J, Beijer B, Bauder-Wüst U, Schäfer M, Leotta K, Eder M, Benešová M, Kleist C, Giesel F, Kratochwil C, Kopka K, Haberkorn U, Mier W.
    J Nucl Med; 2020 Jan; 61(1):70-79. PubMed ID: 31541034
    [Abstract] [Full Text] [Related]

  • 3. Synthesis and structural characterization of copper(I) complexes bearing N-methyl-1,3,5-triaza-7-phosphaadamantane (mPTA): cytotoxic activity evaluation of a series of water soluble Cu(I) derivatives containing PTA, PTAH and mPTA ligands.
    Porchia M, Benetollo F, Refosco F, Tisato F, Marzano C, Gandin V.
    J Inorg Biochem; 2009 Dec; 103(12):1644-51. PubMed ID: 19822369
    [Abstract] [Full Text] [Related]

  • 4. Investigation into 64Cu-labeled Bis(selenosemicarbazone) and Bis(thiosemicarbazone) complexes as hypoxia imaging agents.
    McQuade P, Martin KE, Castle TC, Went MJ, Blower PJ, Welch MJ, Lewis JS.
    Nucl Med Biol; 2005 Feb; 32(2):147-56. PubMed ID: 15721760
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of the Profile and Mechanism of Neurotoxicity of Water-Soluble [Cu(P)4]PF6 and [Au(P)4]PF6 (P = thp or PTA) Anticancer Complexes.
    Ceresa C, Nicolini G, Semperboni S, Gandin V, Monfrini M, Avezza F, Alberti P, Bravin A, Pellei M, Santini C, Cavaletti G.
    Neurotox Res; 2018 Jul; 34(1):93-108. PubMed ID: 29344837
    [Abstract] [Full Text] [Related]

  • 6. 64Cu-azabicyclo[3.2.2]nonane thiosemicarbazone complexes: radiopharmaceuticals for PET of topoisomerase II expression in tumors.
    Wei L, Easmon J, Nagi RK, Muegge BD, Meyer LA, Lewis JS.
    J Nucl Med; 2006 Dec; 47(12):2034-41. PubMed ID: 17138747
    [Abstract] [Full Text] [Related]

  • 7. Cu(I) complexes bearing the new sterically demanding and coordination flexible tris(3-phenyl-1-pyrazolyl)methanesulfonate ligand and the water-soluble phosphine 1,3,5-triaza-7-phosphaadamantane or related ligands.
    Wanke R, Smoleński P, da Silva MF, Martins LM, Pombeiro AJ.
    Inorg Chem; 2008 Nov 03; 47(21):10158-68. PubMed ID: 18841929
    [Abstract] [Full Text] [Related]

  • 8. 198Au-labeled hydroxymethyl phosphines as models for potential therapeutic pharmaceuticals.
    Berning DE, Katti KV, Volkert WA, Higginbotham CJ, Ketring AR.
    Nucl Med Biol; 1998 Aug 03; 25(6):577-83. PubMed ID: 9751426
    [Abstract] [Full Text] [Related]

  • 9. An improved synthesis and biological evaluation of a new cage-like bifunctional chelator, 4-((8-amino-3,6,10,13,16,19-hexaazabicyclo[6.6.6]icosane-1-ylamino)methyl)benzoic acid, for 64Cu radiopharmaceuticals.
    Cai H, Li Z, Huang CW, Park R, Shahinian AH, Conti PS.
    Nucl Med Biol; 2010 Jan 03; 37(1):57-65. PubMed ID: 20122669
    [Abstract] [Full Text] [Related]

  • 10. Synthesis, characterization, and in vitro antitumor properties of tris(hydroxymethyl)phosphine copper(I) complexes containing the new bis(1,2,4-triazol-1-yl)acetate ligand.
    Marzano C, Pellei M, Colavito D, Alidori S, Lobbia GG, Gandin V, Tisato F, Santini C.
    J Med Chem; 2006 Dec 14; 49(25):7317-24. PubMed ID: 17149861
    [Abstract] [Full Text] [Related]

  • 11. Syntheses, in vitro and in vivo characterization of a 99mTc-(I)-tricarbonyl-benzylamino-dihydroxymethyl phosphine (NP(2)) chelate.
    Kothari KK, Raghuraman K, Pillarsetty NK, Hoffman TJ, Owen NK, Katti KV, Volkert WA.
    Appl Radiat Isot; 2003 May 14; 58(5):543-9. PubMed ID: 12735970
    [Abstract] [Full Text] [Related]

  • 12. In vivo behavior of copper-64-labeled methanephosphonate tetraaza macrocyclic ligands.
    Sun X, Wuest M, Kovacs Z, Sherry AD, Motekaitis R, Wang Z, Martell AE, Welch MJ, Anderson CJ.
    J Biol Inorg Chem; 2003 Jan 14; 8(1-2):217-25. PubMed ID: 12459917
    [Abstract] [Full Text] [Related]

  • 13. Design and Preclinical Evaluation of an Albumin-Binding PSMA Ligand for 64Cu-Based PET Imaging.
    Umbricht CA, Benešová M, Hasler R, Schibli R, van der Meulen NP, Müller C.
    Mol Pharm; 2018 Dec 03; 15(12):5556-5564. PubMed ID: 30376344
    [Abstract] [Full Text] [Related]

  • 14. Synthesis and pre-clinical evaluation of a new class of high-affinity 18F-labeled PSMA ligands for detection of prostate cancer by PET imaging.
    Kelly J, Amor-Coarasa A, Nikolopoulou A, Kim D, Williams C, Ponnala S, Babich JW.
    Eur J Nucl Med Mol Imaging; 2017 Apr 03; 44(4):647-661. PubMed ID: 27847991
    [Abstract] [Full Text] [Related]

  • 15. Modification of Biodistribution and Brain Uptake of Copper Bis(thiosemicarbazonato) Complexes by the Incorporation of Amine and Polyamine Functional Groups.
    Paterson BM, Cullinane C, Crouch PJ, White AR, Barnham KJ, Roselt PD, Noonan W, Binns D, Hicks RJ, Donnelly PS.
    Inorg Chem; 2019 Apr 01; 58(7):4540-4552. PubMed ID: 30869878
    [Abstract] [Full Text] [Related]

  • 16. PET Imaging of HER2-Positive Tumors with Cu-64-Labeled Affibody Molecules.
    Qi S, Hoppmann S, Xu Y, Cheng Z.
    Mol Imaging Biol; 2019 Oct 01; 21(5):907-916. PubMed ID: 30617730
    [Abstract] [Full Text] [Related]

  • 17. In vitro antitumour activity of water soluble Cu(I), Ag(I) and Au(I) complexes supported by hydrophilic alkyl phosphine ligands.
    Santini C, Pellei M, Papini G, Morresi B, Galassi R, Ricci S, Tisato F, Porchia M, Rigobello MP, Gandin V, Marzano C.
    J Inorg Biochem; 2011 Feb 01; 105(2):232-40. PubMed ID: 21194623
    [Abstract] [Full Text] [Related]

  • 18. Production and tumour uptake of [64Cu]Pyruvaldehyde-bis (N4-methylthiosemicarbazone) for PET and/or therapeutic purposes.
    Jalilian AR, Rowshanfarzad P, Kamrani YY, Shafaii K, Mirzaii M.
    Nucl Med Rev Cent East Eur; 2007 Feb 01; 10(1):6-11. PubMed ID: 17694494
    [Abstract] [Full Text] [Related]

  • 19. Targeting CAIX with [64Cu]XYIMSR-06 Small Molecular Radiotracer Enables Noninvasive PET Imaging of Malignant Glioma in U87 MG Tumor Cell Xenograft Mice.
    Yang X, Zhu H, Yang X, Li N, Huang H, Liu T, Guo X, Xu X, Xia L, Deng C, Tian X, Yang Z.
    Mol Pharm; 2019 Apr 01; 16(4):1532-1540. PubMed ID: 30803240
    [Abstract] [Full Text] [Related]

  • 20. Syntheses and Biological Studies of Cu(II) Complexes Bearing Bis(pyrazol-1-yl)- and Bis(triazol-1-yl)-acetato Heteroscorpionate Ligands.
    Pellei M, Gandin V, Marchiò L, Marzano C, Bagnarelli L, Santini C.
    Molecules; 2019 May 07; 24(9):. PubMed ID: 31067640
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.